GEN-O-MA project: an Italian network studying clinical course and pathogenic pathways of moyamoya disease—study protocol and preliminary results

[1]  E. Génin,et al.  Rare RNF213 variants in the C-terminal region encompassing the RING-finger domain are associated with moyamoya angiopathy in Caucasians , 2017, European Journal of Human Genetics.

[2]  J. Bang,et al.  Meta-analysis of the surgical outcomes of symptomatic moyamoya disease in adults. , 2017, Journal of neurosurgery.

[3]  M. Fromm,et al.  Autocrine release of angiopoietin-2 mediates cerebrovascular disintegration in Moyamoya disease , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  J. Pekkola,et al.  Moyamoya vasculopathy – Patient demographics and characteristics in the Finnish population , 2017, International journal of stroke : official journal of the International Stroke Society.

[5]  Seung-Chyul Hong,et al.  Determinants of Basal Collaterals in Moyamoya Disease: Clinical and Genetic Factors , 2016, European Neurology.

[6]  P. Ferroli,et al.  Vasculogenic and Angiogenic Pathways in Moyamoya Disease. , 2016, Current medicinal chemistry.

[7]  A. van der Zwan,et al.  Research Progresses in Understanding the Pathophysiology of Moyamoya Disease , 2016, Cerebrovascular Diseases.

[8]  Edward R. Smith,et al.  Moyamoya: defining current knowledge gaps , 2015, Developmental medicine and child neurology.

[9]  P. Vajkoczy,et al.  Distinct clinical and radiographic characteristics of moyamoya disease amongst European Caucasians , 2015, European journal of neurology.

[10]  R. Zong,et al.  Clinical Features, Surgical Treatment, and Long-Term Outcome in Pediatric Patients with Moyamoya Disease in China , 2015, Cerebrovascular Diseases.

[11]  M. Strother,et al.  Cerebrovascular Collaterals Correlate with Disease Severity in Adult North American Patients with Moyamoya Disease , 2014, American Journal of Neuroradiology.

[12]  P. Huh,et al.  Clinical and Angiographic Features and Stroke Types in Adult Moyamoya Disease , 2014, American Journal of Neuroradiology.

[13]  S. Roman,et al.  Loss of α1β1 soluble guanylate cyclase, the major nitric oxide receptor, leads to moyamoya and achalasia. , 2014, American journal of human genetics.

[14]  A. Koizumi,et al.  Genomewide association study identifies no major founder variant in Caucasian moyamoya disease , 2013, Journal of Genetics.

[15]  Grant W. Mallory,et al.  Moyamoya Disease in a Primarily White, Midwestern US Population: Increased Prevalence of Autoimmune Disease , 2013, Stroke.

[16]  A. Qureshi,et al.  Epidemiological and Clinical Features of Moyamoya Disease in the USA , 2013, Neuroepidemiology.

[17]  R. Zong,et al.  Clinical Features, Surgical Treatment and Long-Term Outcome in Adult Patients with Moyamoya Disease in China , 2012, Cerebrovascular Diseases.

[18]  L. Regli,et al.  Regional differences in incidence and patient characteristics of moyamoya disease: a systematic review , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[19]  A. Silvani,et al.  Decrease in circulating endothelial progenitor cells in treated glioma patients , 2012, Journal of Neuro-Oncology.

[20]  S. Gazal,et al.  Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya. , 2011, American journal of human genetics.

[21]  F. Heppner,et al.  Proposal for a New Grading of Moyamoya Disease in Adult Patients , 2011, Cerebrovascular Diseases.

[22]  E. Connolly,et al.  Optimal surgical treatment for moyamoya disease in adults: direct versus indirect bypass. , 2009, Neurosurgical focus.

[23]  P. Berlit,et al.  Moyamoya Disease in Europeans , 2008, Stroke.

[24]  S. Kuroda,et al.  Moyamoya disease: current concepts and future perspectives , 2008, The Lancet Neurology.

[25]  C. Bono,et al.  Pedicle subtraction osteotomy in the treatment of chronic, posttraumatic kyphotic deformity. , 2006, Journal of neurosurgery. Spine.

[26]  M. Fukui.  Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. , 1997, Clinical neurology and neurosurgery.

[27]  Y. Yonekawa,et al.  Moyamoya disease in Europe, past and present status , 1997, Clinical Neurology and Neurosurgery.

[28]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[29]  G. Bernardi,et al.  Effect of Smoking on Cerebrovascular Reactivity , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[30]  H. Markus,et al.  Estimation of Cerebrovascular Reactivity Using Transcranial Doppler, Including the Use of Breath‐Holding as the Vasodilatory Stimulus , 1992, Stroke.

[31]  A Takaku,et al.  Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. , 1969, Archives of neurology.

[32]  N. Suzuki,et al.  Epidemiological features of moyamoya disease in Japan. , 2012, Neurologia medico-chirurgica.

[33]  M. Tatagiba,et al.  Genetic and clinical characteristics of Moyamoya disease in Europeans. , 2011, Acta neurochirurgica. Supplement.

[34]  吉井 信夫.  Spontaneous occlusion of the circle of willis : moyamoya disease , 2009 .

[35]  K. Houkin,et al.  Effects of surgical revascularization on outcome of patients with pediatric moyamoya disease. , 1997, Stroke.

[36]  D. Hervé,et al.  Moyamoya disease and syndromes: from genetics to clinical management , 2015, The application of clinical genetics.